Tumor response based on adapted Macdonald criteria and assessment of pseudoprogression (PsPD) in the phase III AV Aglio trial of bevacizumab (Bv) plus temozolomide (T) plus radiotherapy (RT) in newly diagnosed glioblastoma (GBM)

被引：0
|
作者：
Wick, Wolfgang
Cloughesy, Timothy Francis
Nishikawa, Ryo
Mason, Warren
Saran, Frank
Henriksson, Roger
Hilton, Magalie
Kerloeguen, Yannick
Chinot, Oliver L.
机构：
[1] Heidelberg Univ, Med Ctr, Heidelberg, Germany
[2] Univ Calif Los Angeles, Los Angeles, CA USA
[3] Saitama Med Univ, Int Med Ctr, Saitama, Japan
[4] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[5] Royal Marsden NHS Fdn Trust, London, England
[6] Reg Canc Ctr Stockholm, Stockholm, Sweden
[7] Umea Univ Hosp, Stockholm, Sweden
[8] F Hoffmann La Roche Ltd, Basel, Switzerland
[9] Aix Marseille Univ, CHU Timone, AP HM, Serv Neurooncol, Marseille, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2002
引用
收藏
页数：1
相关论文
共 28 条
  • [1] Biomarker (BM) evaluations in the phase III AVAglio study of bevacizumab (Bv) plus standard radiotherapy (RT) and temozolomide (T) for newly diagnosed glioblastoma (GBM)
    Nishikawa, Ryo
    Saran, Frank
    Mason, Warren
    Wick, Wolfgang
    Cloughesy, Timothy Francis
    Henriksson, Roger
    Hilton, Magalie
    Garcia, Josep
    Vogt, Tobias
    Pallaud, Celine
    Chinot, Oliver L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma
    Wick, Wolfgang
    Chinot, Olivier L.
    Bendszus, Martin
    Mason, Warren
    Henriksson, Roger
    Saran, Frank
    Nishikawa, Ryo
    Revil, Cedric
    Kerloeguen, Yannick
    Cloughesy, Timothy
    [J]. NEURO-ONCOLOGY, 2016, 18 (10) : 1434 - 1441
  • [3] AVAglio: Phase 3 Trial of Bevacizumab Plus Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
    Chinot, O. L.
    Rouge, T. de la Motte
    Moore, N.
    Zeaiter, A.
    Das, A.
    Phillips, H.
    Modrusan, Z.
    Cloughesy, T.
    [J]. ADVANCES IN THERAPY, 2011, 28 (04) : 334 - 340
  • [4] AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
    O. L. Chinot
    T. de La Motte Rouge
    N. Moore
    A. Zeaiter
    A. Das
    H. Phillips
    Z. Modrusan
    T. Cloughesy
    [J]. Advances in Therapy, 2011, 28 : 334 - 340
  • [5] RE-ANALYSIS OF PFS/RESPONSE USING ORIGINAL MACDONALD CRITERIA AND RESPONSE EVALUATION CRITERIA IN SOLID TUMORS IN THE PHASE III AVAGLIO STUDY OF BEVACIZUMAB PLUS RADIOTHERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA
    Chinot, Olivier L.
    Wick, Wolfgang
    van den Bent, Martin J.
    Mason, Warren
    Henriksson, Roger
    Saran, Frank
    Nishikawa, Ryo
    Revil, Cedric
    Kerloeguen, Yannick
    Cloughesy, Timothy
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [6] SAFETY RESULTS FROM AVAglio, A PHASE III RANDOMIZED STUDY OF BEVACIZUMAB (BEV) PLUS STANDARD COMBINATION TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Saran, Frank
    Chinot, Olivier L.
    Henriksson, Roger
    Mason, Warren
    Wick, Wolfgang
    Nishikawa, Ryo
    Dahr, Sunita
    Hilton, Magalie
    Garcia, Josep
    Cloughesy, Timothy
    [J]. NEURO-ONCOLOGY, 2013, 15 : 127 - 128
  • [7] Phase III TRIDENT trial: Radiation and temozolomide plus /- tumor treating fields in newly diagnosed glioblastoma.
    Shi, Wenyin
    Kleinberg, Lawrence
    Jeyapalan, Suriya A.
    Goldlust, Samuel Aaron
    Nagpal, Seema
    Reardon, David A.
    Combs, Stephanie E.
    Roberge, David
    Nishigawa, Ryo
    Glas, Martin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] FINAL EFFICACY AND SAFETY RESULTS FROM AVAglio, A PHASE III TRIAL OF BEVACIZUMAB (BEV) PLUS TEMOZOLOMIDE (TMZ) ANDRADIOTHERAPY (RT) IN NEWLY DIAGNOSED GLIOBLASTOMA
    Chinot, Olivier L.
    Wick, Wolfgang
    Mason, Warren
    Henriksson, Roger
    Saran, Frank
    Nishikawa, Ryo
    Carpentier, Antoine F.
    Khe Hoang-Xuan
    Kavan, Petr
    Cernea, Dana
    Brandes, Alba A.
    Hilton, Magalie
    Kerloeguen, Yannick
    Guijarro, Abajo
    Cloughsey, Timothy
    [J]. NEURO-ONCOLOGY, 2013, 15 : 105 - 106
  • [9] Efficacy and safety of bevacizumab (By) plus standard combination temozolomide (T) and radiotherapy (RT) in newly diagnosed glioblastoma: final results from AVAglio
    Chinot, O.
    Cloughesy, T.
    Henriksson, R.
    Saran, F.
    Mason, W.
    Nishikawa, R.
    Hilton, M.
    Abrey, L.
    Wick, W.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S774 - S775
  • [10] PHASE 2 TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) PLUS RADIATION THERAPY (RT) PLUS TEMOZOLAMIDE (TMZ) COMPARED TO RT PLUS TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)
    Grossman, Rachel
    Limon, Dror
    Bokstein, Felix
    Ben Harosh, Carmit
    Blumenthal, Deborah
    Ram, Zvi
    [J]. NEURO-ONCOLOGY, 2020, 22 : 196 - 196
123